EP Patent

EP2456444A1 — Certain chemical entities, compositions and methods

Assigned to Intellikine LLC · Expires 2012-05-30 · 14y expired

What this patent protects

Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PO kinase activity are described herein.

USPTO Abstract

Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with PO kinase activity are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP2456444A1
Jurisdiction
EP
Classification
—
Expires
2012-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Intellikine LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.